Medical Laboratories (Services) Companies
FilingsAtlas covers 23 publicly traded US companies in the Medical Laboratories (Services) industry (SEC SIC code 8071). Together they are worth about $171.37B in market value; the largest are Natera (NTRA), Quest Diagnostics (DGX), Labcorp (LH). By revenue, the biggest is Labcorp with $13.95B in fiscal 2025. 6 of the 23 companies with a reported fiscal year were profitable.
| # | Company | Ticker | Market Cap | Revenue (latest FY) | Net Income | Revenue YoY | P/E |
|---|---|---|---|---|---|---|---|
| 1 | Natera, Inc. | NTRA | $56.69B | $2.31B FY2025 | -$208.2M | +35.9% | — |
| 2 | Quest Diagnostics Inc | DGX | $25.81B | $11.04B FY2025 | $992.0M | +11.8% | 26.3 |
| 3 | Labcorp Holdings Inc. | LH | $25.72B | $13.95B FY2025 | $876.5M | +7.2% | 30.0 |
| 4 | Guardant Health, Inc. | GH | $21.54B | $982.0M FY2025 | -$416.3M | +32.9% | — |
| 5 | Caris Life Sciences, Inc. | CAI | $8.35B | $812.0M FY2025 | -$68.1M | — | — |
| 6 | GRAIL, Inc. | GRAL | $6.05B | $147.2M FY2025 | -$408.4M | +17.2% | — |
| 7 | RadNet, Inc. | RDNT | $5.63B | $2.04B FY2025 | -$18.7M | +11.5% | — |
| 8 | BillionToOne, Inc. | BLLN | $5.14B | $305.1M FY2025 | $7.5M | — | 674.6 |
| 9 | Veracyte, Inc. | VCYT | $3.54B | $517.1M FY2025 | $66.4M | +16.0% | 52.6 |
| 10 | CareDx, Inc. | CDNA | $3.50B | $379.8M FY2025 | -$21.4M | +13.8% | — |
| 11 | Celcuity Inc. | CELC | $3.46B | $0 FY2025 | -$177.0M | — | — |
| 12 | Fortrea Holdings Inc. | FTRE | $1.98B | $2.72B FY2025 | -$986.2M | +1.0% | — |
| 13 | Personalis, Inc. | PSNL | $1.67B | $69.6M FY2025 | -$81.3M | -17.7% | — |
| 14 | Castle Biosciences Inc | CSTL | $999.5M | $344.2M FY2025 | -$24.2M | +3.7% | — |
| 15 | Fulgent Genetics, Inc. | FLGT | $589.8M | $322.7M FY2025 | -$60.5M | +13.8% | — |
| 16 | Biodesix Inc | BDSX | $257.4M | $88.5M FY2025 | -$35.3M | +24.1% | — |
| 17 | Exagen Inc. | XGN | $204.9M | $66.6M FY2025 | -$20.0M | +19.7% | — |
| 18 | Perceptive Capital Solutions Corp | PCSC | $106.9M | $0 FY2025 | $837,468 | — | 158.0 |
| 19 | Sera Prognostics, Inc. | SERA | $103.0M | $81,000 FY2025 | -$31.9M | +5.2% | — |
| 20 | American Shared Hospital Services | AMS | $8.7M | $28.1M FY2025 | -$1.6M | -0.9% | — |
| 21 | Advanced Biomed Inc. | ADVB | $6.5M | $127,637 FY2026 | $6.7M | — | 1.0 |
| 22 | Aclarion, Inc. | ACON | $5.3M | $75,730 FY2025 | -$7.2M | +65.6% | — |
| 23 | BioNexus Gene Lab Corp | BGLC | $3.2M | $7.4M FY2025 | -$3.0M | -21.9% | — |
Market cap and P/E use the latest closing price; revenue and net income are from each company's most recent annual report (10-K) filed with the SEC. Click a company for its full financial statements.